Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Anderson

Showing results (231-240 of 270) with videos related to

Pageof 27
Sort By:
Spine|October 2, 2007
The subaxial cervical spine injury classification system: a novel approach to recognize the importance of morphology, neurology, and integrity of the disco-ligamentous complexAlexander R Vaccaro, R John Hulbert, Alpesh A Patel, et al.
Current Chemical Genomics|February 18, 2010
Cellular Ser/Thr-kinase assays using generic peptide substratesDeanna G Adams, Yu Wang, Puiying A Mak, et al.
BJU International|October 11, 2019
Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urology|April 26, 2022
WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc ProstatesAnis Assad, David-Dan Nguyen, Neil Barber, et al.
The Journal of Cell Biology|April 25, 2020
FXR1 splicing is important for muscle development and biomolecular condensates in muscle cellsJean A Smith, Ennessa G Curry, R Eric Blue, et al.
BJUI Compass|November 14, 2024
WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> prostatesMohamad Baker Berjaoui, David-Dan Nguyen, Saud Almousa, et al.
European Urology Open Science|August 2, 2021
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> ProstatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
BJU International|June 5, 2018
Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trialMark Plante, Peter Gilling, Neil Barber, et al.
The Journal of Urology|January 24, 2018
WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation<sup>®</sup> vs Transurethral Resection of the Prostate in Benign Prostatic HyperplasiaPeter Gilling, Neil Barber, Mohamed Bidair, et al.
ACS Infectious Diseases|May 19, 2015
A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin ProteinKris M White, Paul De Jesus, Zhong Chen, et al.
Pageof 27

Showing results (231-240 of 270) with videos related to

Sort By:
Pageof 27
Spine|October 2, 2007
The subaxial cervical spine injury classification system: a novel approach to recognize the importance of morphology, neurology, and integrity of the disco-ligamentous complexAlexander R Vaccaro, R John Hulbert, Alpesh A Patel, et al.
Current Chemical Genomics|February 18, 2010
Cellular Ser/Thr-kinase assays using generic peptide substratesDeanna G Adams, Yu Wang, Puiying A Mak, et al.
BJU International|October 11, 2019
Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urology|April 26, 2022
WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc ProstatesAnis Assad, David-Dan Nguyen, Neil Barber, et al.
The Journal of Cell Biology|April 25, 2020
FXR1 splicing is important for muscle development and biomolecular condensates in muscle cellsJean A Smith, Ennessa G Curry, R Eric Blue, et al.
BJUI Compass|November 14, 2024
WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> prostatesMohamad Baker Berjaoui, David-Dan Nguyen, Saud Almousa, et al.
European Urology Open Science|August 2, 2021
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> ProstatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
BJU International|June 5, 2018
Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trialMark Plante, Peter Gilling, Neil Barber, et al.
The Journal of Urology|January 24, 2018
WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation<sup>®</sup> vs Transurethral Resection of the Prostate in Benign Prostatic HyperplasiaPeter Gilling, Neil Barber, Mohamed Bidair, et al.
ACS Infectious Diseases|May 19, 2015
A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin ProteinKris M White, Paul De Jesus, Zhong Chen, et al.
Pageof 27